3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
12
Lung Neoplasms
9
Melanoma
5
Head and Neck Neoplasms
5
Stomach Neoplasms
4
Neoplasms
4
Neoplasm Metastasis
4
Breast Neoplasms
4
Small Cell Lung Carcinoma
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Thymus Neoplasms
2
Skin Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Multiple Myeloma
2
Kidney Neoplasms
2
Glioblastoma
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Astrocytoma
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Surveys and Questionnaires
22
Blood Specimen Collection
13
niraparib
8
Cytoreduction Surgical Procedures
8
Hyperthermic Intraperitoneal Chemotherapy
7
Interviews as Topic
6
Immunohistochemistry
6
olaparib
5
Psychiatric Rehabilitation
5
Polymerase Chain Reaction
5
Magnetic Resonance Spectroscopy
5
Data Collection
5
Carboplatin
5
Amplified Fragment Length Polymorphism Analysis
5
liposomal doxorubicin
4
Geriatric Assessment
4
Bevacizumab
4
1-dodecylpyridoxal
4
Ultrasonography
3
Trabectedin
3
Therapeutics
3
Poly(ADP-ribose) Polymerase Inhibitors
3
Phlebotomy
3
Observation
3
Neoadjuvant Therapy
3
Microarray Analysis
3
Laparoscopy
3
Gene Expression Profiling
3
Flow Cytometry
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Ovarian Neoplasms
×
Immunotherapy
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled